SEGRA INTERNATIONAL CORP.: federal grants and contributions: 8 agreements; $1.5M value; 1 departments; 3 programs.
Assay record ASY-CA-09MUBST19F · Cite as: Assay Systems, “SEGRA INTERNATIONAL CORP.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/segra-international-corp/
As part of the international consortium project “CANNABIS-PHARMA”, the project aims to select and investigate cannabigerol-enriched cannabis plants that have anti-inflammatory and analgesic therapeutic value, using polyploidy and molecular fingerprinting technologies.
Firm will select and investigate Type 3 cultivars (high CBD/low THC) of Cannabis plants that have therapeutic value to create a tissue culture protocol utilizing protoplast culture technology.
This project aims to develop and optimize reusable Temporary Immersion System bioreactors for the efficient micropropagation of genetically-diverse cannabis cultivars.
This proof-of-concept project aims to develop an RNA-based biopesticide prototype to combat Hop Latent Viroid (HLVd) infections in high-value crops.
Youth will be part of the team to develop an automated bioreactor for plant production in tissue culture.
This Youth project is focused on the design and implementation of improved automated media dispensing and cleaning systems for the Firm's plant tissue culture processing facility.
Development of components of a Bioreactor System for Large-Scale Cannabis Plant Tissue Culture.
Youth - Plant Cultivation
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.